• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素 P450 氧化还原酶遗传多态性 A503V 和 rs2868177 不显著影响汉族机械心脏瓣膜置换术后患者华法林的稳定剂量。

Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement.

机构信息

Institute of Clinical Pharmacology, Central South University, Changsha, China, 410078.

出版信息

Eur J Clin Pharmacol. 2013 Oct;69(10):1769-75. doi: 10.1007/s00228-013-1544-2. Epub 2013 Aug 16.

DOI:10.1007/s00228-013-1544-2
PMID:23949431
Abstract

PURPOSE

To investigate the influence of cytochrome P450 oxidoreductase (POR) polymorphisms (A503V and rs2868177) on warfarin stable dosage (WSD) in Han-Chinese patients with mechanical heart valve replacement (MHVR).

METHODS

Three hundred and seventeen Han-Chinese MHVR patients on stable maintenance dose of warfarin were enrolled. Blood samples were collected for genotyping analyses of VKORC1 -1639G>A, CYP2C9 *3, CYP4F2 rs2108622 and POR (A503V and rs2868177). Average WSD of carriers with variant POR genotypes or haplotypes were compared. Association analyses were performed by single and multiple linear regression analysis.

RESULTS

The variant allele frequencies of POR polymorphisms (A503V and rs2868177) were 38.8 % and 44.8 %, respectively. D' between POR A503V and rs2868177 was 0.855, r(2) was 0.375, and the frequencies of the four POR haplotypes were 42.3 % for CG, 36.3 % for TA, 18.9 % for CA, and 2.5 % for TG, respectively. There were no significant differences in average WSD among carriers with three variant POR A503V genotypes or among carriers with three variant POR rs2868177 genotypes (both P > 0.05). Similarly, there were no significant differences in average WSD among carriers with variant POR haplotypes (all P > 0.05). Neither single nor multiple linear regression analyses showed significant effects of POR A503V or POR rs2868177 polymorphisms on WSD.

CONCLUSION

POR polymorphisms (A503V and rs2868177) do not appear to significantly influence WSD in Han-Chinese patients with MHVR.

摘要

目的

研究细胞色素 P450 氧化还原酶(POR)多态性(A503V 和 rs2868177)对汉族机械心脏瓣膜置换(MHVR)患者华法林稳定剂量(WSD)的影响。

方法

纳入 317 例服用华法林稳定维持剂量的汉族 MHVR 患者。采集血样进行 VKORC1-1639G>A、CYP2C9*3、CYP4F2 rs2108622 和 POR(A503V 和 rs2868177)的基因分型分析。比较携带变异 POR 基因型或单倍型的患者的平均 WSD。采用单因素和多因素线性回归分析进行关联分析。

结果

POR 多态性(A503V 和 rs2868177)的变异等位基因频率分别为 38.8%和 44.8%。POR A503V 和 rs2868177 之间的 D'为 0.855,r(2)为 0.375,4 种 POR 单倍型的频率分别为 CG 型 42.3%、TA 型 36.3%、CA 型 18.9%和 TG 型 2.5%。携带三种变异 POR A503V 基因型或携带三种变异 POR rs2868177 基因型的患者之间的平均 WSD 无显著差异(均 P>0.05)。同样,携带变异 POR 单倍型的患者之间的平均 WSD 也无显著差异(均 P>0.05)。单因素和多因素线性回归分析均未显示 POR A503V 或 POR rs2868177 多态性对 WSD 有显著影响。

结论

POR 多态性(A503V 和 rs2868177)似乎对华法林在汉族 MHVR 患者中的稳定剂量无明显影响。

相似文献

1
Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement.细胞色素 P450 氧化还原酶遗传多态性 A503V 和 rs2868177 不显著影响汉族机械心脏瓣膜置换术后患者华法林的稳定剂量。
Eur J Clin Pharmacol. 2013 Oct;69(10):1769-75. doi: 10.1007/s00228-013-1544-2. Epub 2013 Aug 16.
2
CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.CYP4F2 rs2108622:汉族机械心脏瓣膜置换患者华法林剂量的次要显著遗传因素。
Br J Clin Pharmacol. 2010 Aug;70(2):234-40. doi: 10.1111/j.1365-2125.2010.03698.x.
3
Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose.鉴定细胞色素 P450 氧化还原酶基因变异,这些变异与华法林维持剂量的个体间差异显著相关。
Drug Metab Dispos. 2011 Aug;39(8):1433-9. doi: 10.1124/dmd.111.038836. Epub 2011 May 11.
4
Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients.CYP2C9*3、VKORC1-1639、CYP4F2rs2108622 基因多态性及临床因素对汉族华法林维持剂量的影响。
J Thromb Thrombolysis. 2012 Jul;34(1):120-5. doi: 10.1007/s11239-012-0725-7.
5
A new algorithm to predict warfarin dose from polymorphisms of CYP4F2 , CYP2C9 and VKORC1 and clinical variables: derivation in Han Chinese patients with non valvular atrial fibrillation.一种新的算法,可根据 CYP4F2、CYP2C9 和 VKORC1 的多态性以及临床变量预测华法林剂量:在非瓣膜性心房颤动的汉族患者中的推导。
Thromb Haemost. 2012 Jun;107(6):1083-91. doi: 10.1160/TH11-12-0848. Epub 2012 Apr 26.
6
The association between GGCX, miR-133 genetic polymorphisms and warfarin stable dosage in Han Chinese patients with mechanical heart valve replacement.汉族机械心脏瓣膜置换患者中GGCX、miR-133基因多态性与华法林稳定剂量的相关性
J Clin Pharm Ther. 2017 Aug;42(4):438-445. doi: 10.1111/jcpt.12527. Epub 2017 Apr 21.
7
Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.机械心脏瓣膜患者尿苷二磷酸葡萄糖醛酸转移酶多态性对稳定华法林剂量的影响。
Cardiovasc Ther. 2015 Dec;33(6):324-8. doi: 10.1111/1755-5922.12147.
8
Prediction of warfarin maintenance dose in Han Chinese patients using a mechanistic model based on genetic and non-genetic factors.基于遗传和非遗传因素的机制模型预测汉族华法林维持剂量。
Clin Pharmacokinet. 2013 Jul;52(7):567-81. doi: 10.1007/s40262-013-0054-9.
9
Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.VKORC1、CYP4F2和NQO1基因变异对汉族心房颤动导管消融患者华法林剂量需求的影响
BMC Cardiovasc Disord. 2018 May 18;18(1):96. doi: 10.1186/s12872-018-0837-x.
10
Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.在印度尼西亚人群中,与 VKORC1、CYP2C9、CYP2C19 和 CYP4F2 基因变异相关的低剂量华法林反应。
Eur J Clin Pharmacol. 2013 Mar;69(3):395-405. doi: 10.1007/s00228-012-1356-9. Epub 2012 Aug 2.

引用本文的文献

1
COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment.COVID-19 疫苗接种会影响华法林治疗中的短期抗凝水平。
J Thromb Thrombolysis. 2024 Apr;57(4):730-738. doi: 10.1007/s11239-024-02959-2. Epub 2024 Mar 25.
2
Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies.遗传因素对汉族人群华法林剂量的影响:队列研究的系统评价和荟萃分析。
Clin Pharmacokinet. 2023 Jun;62(6):819-833. doi: 10.1007/s40262-023-01258-y. Epub 2023 Jun 5.
3
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.

本文引用的文献

1
Development and comparison of a new personalized warfarin stable dose prediction algorithm in Chinese patients undergoing heart valve replacement.一种用于接受心脏瓣膜置换术的中国患者的新型华法林稳定剂量预测算法的开发与比较
Pharmazie. 2012 Nov;67(11):930-7.
2
Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy.细胞色素 P450 氧化还原酶的遗传药理学:对药物代谢和治疗的影响。
Pharmacogenet Genomics. 2012 Nov;22(11):812-9. doi: 10.1097/FPC.0b013e328358d92b.
3
Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking.
CYP4F2、VKORC1 和 CYP2C9 对香豆素剂量影响的作用:超过 15000 个人的单患者数据荟萃分析。
Clin Pharmacol Ther. 2019 Jun;105(6):1477-1491. doi: 10.1002/cpt.1323. Epub 2019 Feb 17.
4
Frequency of Common VKORC1 Polymorphisms and Their Impact on Warfarin Dose Requirement in Pakistani Population.巴基斯坦人群中常见维生素K环氧化物还原酶复合体亚单位1(VKORC1)多态性的频率及其对华法林剂量需求的影响
Clin Appl Thromb Hemost. 2018 Mar;24(2):323-329. doi: 10.1177/1076029616680478. Epub 2016 Nov 22.
5
Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis.CYP2C9、VKORC1和CYP4F2基因多态性对汉族患者华法林维持剂量的影响:一项系统评价和荟萃分析。
Meta Gene. 2016 Jul 5;9:197-209. doi: 10.1016/j.mgene.2016.07.002. eCollection 2016 Sep.
6
Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese.细胞色素P450氧化还原酶基因多态性对汉族人群华法林稳定维持剂量变异性的影响。
Eur J Clin Pharmacol. 2016 Nov;72(11):1327-1334. doi: 10.1007/s00228-016-2098-x. Epub 2016 Aug 4.
7
The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity.细胞色素P450氧化还原酶(POR)基因rs2868177位点多态性和细胞色素P450(CYP)2B6*6基因多态性可导致人类CYP2B6活性的个体差异。
Eur J Clin Pharmacol. 2016 Oct;72(10):1205-1213. doi: 10.1007/s00228-016-2095-0. Epub 2016 Jul 20.
细胞色素 P450 氧化还原酶遗传多态性对 CYP1A2 活性和吸烟诱导的影响。
Pharmacogenet Genomics. 2012 Feb;22(2):143-51. doi: 10.1097/FPC.0b013e32834e9e1a.
4
Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese men.CYP 氧化还原酶 Ala503Val 多态性对中国健康男性体内 CYP3A 活性的影响:一项随机、开放标签、交叉研究。
Clin Ther. 2011 Dec;33(12):2060-70. doi: 10.1016/j.clinthera.2011.11.004.
5
CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects.CYP4F2 基因多态性可影响日本人群华法林的维持剂量。
J Clin Pharm Ther. 2012 Aug;37(4):481-5. doi: 10.1111/j.1365-2710.2011.01317.x. Epub 2011 Dec 16.
6
Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose.鉴定细胞色素 P450 氧化还原酶基因变异,这些变异与华法林维持剂量的个体间差异显著相关。
Drug Metab Dispos. 2011 Aug;39(8):1433-9. doi: 10.1124/dmd.111.038836. Epub 2011 May 11.
7
Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms.人类细胞色素P450氧化还原酶基因的转录调控:激素调节及启动子多态性的影响
Mol Endocrinol. 2011 May;25(5):715-31. doi: 10.1210/me.2010-0236. Epub 2011 Mar 10.
8
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.人类 P450 氧化还原酶遗传变异对 CYP2D6 体外催化作用的影响。
Pharmacogenet Genomics. 2010 Nov;20(11):677-86. doi: 10.1097/FPC.0b013e32833f4f9b.
9
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase.细胞色素 P450 氧化还原酶遗传变异对 CYP3A4 活性的底物特异性调节。
Pharmacogenet Genomics. 2010 Oct;20(10):611-8. doi: 10.1097/FPC.0b013e32833e0cb5.
10
CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.CYP4F2 rs2108622:汉族机械心脏瓣膜置换患者华法林剂量的次要显著遗传因素。
Br J Clin Pharmacol. 2010 Aug;70(2):234-40. doi: 10.1111/j.1365-2125.2010.03698.x.